University of Illinois at Chicago
Announcement of an Exempt Purchase
Guerbet, LLCPrinceton, NJ
- Amount: An estimated $750,000
- Terms: An estimated start date of 7/1/2022 through 6/30/2025
- Renewals: None
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Monday, April 18, 2022
The University awarded a contract for Lipiodol (ethiodized oil) Injection.
Lipiodol (ethiodized oil) injection is an oil-based radio-opaque contrast agent.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Lipiodol (ethiodized oil) injection is an oil-based radio-opaque contrast agent indicated for selective hepatic intra-arterial use in adults with hepatocelluar carcinoma. It is combined with chemotherapeutic agents and then injected into the hepatic artery to treat hepatocellular carcinoma. If we are unable to purchase Lipiodol, UI Health will not be able to provide this life saving treatment and patients will have to be referred to other medical centers.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.